Pharmabiz2 小时
GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.
GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.
Inhibikase Announces Expansion of Senior Leadership Team
Chris Cabell, MD MHS FACC Appointed President and Head of Research & Development ------ John Adams, PhD Appointed Chief Scientific ...
PharmiWeb19 小时
GSK completes acquisition of IDRx, Inc.
GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, ...
Buy21 小时
GSK completes GBP1 billion IDRx purchase; starts GBP2 billion buyback
GSK on Monday also said it has start the GBP2 billion buyback programme that it announced earlier this month, starting with an initial GBP700 million tranche.